Biomaterials Designed to Modulate Reactive Oxygen Species for Enhanced Bone Regeneration in Diabetic Conditions
Source abstract
Abstract
Diabetes mellitus, characterized by enduring hyperglycemia, precipitates oxidative stress, engendering a spectrum of complications, notably increased bone vulnerability. The genesis of reactive oxygen species (ROS), a byproduct of oxygen metabolism, instigates oxidative detriment and impairs bone metabolism in diabetic conditions. This review delves into the mechanisms of ROS generation and its impact on bone homeostasis within the context of diabetes. Furthermore, the review summarizes the cutting-edge progress in the development of ROS-neutralizing biomaterials tailored for the amelioration of diabetic osteopathy. These biomaterials are engineered to modulate ROS dynamics, thereby mitigating inflammatory responses and facilitating bone repair. Additionally, the challenges and therapeutic prospects of ROS-targeted biomaterials in clinical application of diabetic bone disease treatment is addressed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
Funding
National Natural Science Foundation of China · International Orthodontics Foundation Young Grants Award
References (100+)
Show source-provided references
1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies10.1016/S0140-6736(10)60484-9 ↗
2. Magliano, D.J., and Boyko, E.J. (2021). IDF Diabetes Atlas 10th Edition Scientific Committee. IDF Diabetes Atlas, International Diabetes Federation©.
3. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: National cross sectional study10.1136/bmj.m997 ↗
4. Oxidative stress, insulin signaling, and diabetes10.1016/j.freeradbiomed.2010.12.006 ↗
5. Diabetes mellitus and the risk of fractures at specific sites: A meta-analysis10.1136/bmjopen-2018-024067 ↗
6. Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature10.1007/s11914-022-00740-z ↗
7. Oxidative stress and diabetic complications10.1161/CIRCRESAHA.110.223545 ↗
8. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: Avenues for a mechanistic-based therapeutic approach10.2174/157339911797415585 ↗
9. Fink, G. (2019). Chapter 13—Oxidative Stress: Eustress and Distress in Redox Homeostasis. Stress: Physiology, Biochemistry, and Pathology, Academic Press.
10. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
11. Biomimetic Materials and Fabrication Approaches for Bone Tissue Engineering10.1002/adhm.201700612 ↗
12. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives10.1016/j.freeradbiomed.2022.03.019 ↗
13. Oxidative stress in bone remodeling: Role of antioxidants10.11138/ccmbm/2017.14.1.209 ↗
14. Clarifying the supercomplex: The higher-order organization of the mitochondrial electron transport chain10.1038/nsmb.3460 ↗
15. The architecture of respiratory supercomplexes10.1038/nature19774 ↗
16. Bhattacharjee, S., and Bhattacharjee, S. (2019). ROS and oxidative stress: Origin and implication. Reactive Oxygen Species in Plant Biology, Springer.10.1007/978-81-322-3941-3 ↗
17. Effects of N-[Imino(1-Piperidinyl)Methyl] Guanidine on the Intensity of Free Radical Processes, Aconitase Activity, and Citrate Level in the Tissues of Rats with Experimental Type 2 Diabetes Mellitus10.1007/s10517-016-3391-5 ↗
18. Possible pharmacological correction of metabolic impairments experimental diabetes mellitus by antioxidant
19. Hernansanz-Agustín, P., and Enríquez, J.A. (2021). Generation of reactive oxygen species by mitochondria. Antioxidants, 10.10.3390/antiox10030415 ↗
20. The pathobiology of diabetic complications: A unifying mechanism10.2337/diabetes.54.6.1615 ↗
21. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology10.1073/pnas.0511154103 ↗
22. High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission10.1089/ars.2010.3284 ↗
23. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells10.1016/S0006-291X(02)02832-2 ↗
24. Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes10.1042/bj2450243 ↗
25. Increased superoxide anion formation in endothelial cells during hyperglycemia: An adaptive response or initial step of vascular dysfunction?10.1016/S0168-8227(99)00045-5 ↗
26. Li, S., Deng, J., Sun, D., Chen, S., Yao, X., Wang, N., Zhang, J., Gu, Q., Zhang, S., and Wang, J. (2022). FBXW7 alleviates hyperglycemia-induced endothelial oxidative stress injury via ROS and PARP inhibition. Redox Biol., 58.10.1016/j.redox.2022.102530 ↗
27. DNA Damage and Repair in Diabetes Mellitus and Its Complications
28. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells10.1172/JCI18127 ↗
29. Mitochondria, oxidative stress and cell death10.1007/s10495-007-0756-2 ↗
30. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options10.1210/er.2004-0028 ↗
31. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway10.1002/ame2.12001 ↗
32. Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications
33. Role of pseudohypoxia in the pathogenesis of type 2 diabetes10.2147/HP.S202775 ↗
34. Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes10.1016/j.jdiacomp.2016.04.019 ↗
35. Activation of protein kinase C isoforms and its impact on diabetic complications10.1161/CIRCRESAHA.110.217117 ↗
36. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C—dependent activation of NAD(P)H oxidase in cultured vascular cells10.2337/diabetes.49.11.1939 ↗
37. Cell signaling through protein kinase C oxidation and activation10.3390/ijms130910697 ↗
38. Molecular pathways associated with oxidative stress in diabetes mellitus10.1016/j.biopha.2018.09.058 ↗
39. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation10.1073/pnas.97.22.12222 ↗
40. Lund, J., Ouwens, D.M., Wettergreen, M., Bakke, S.S., Thoresen, G.H., and Aas, V. (2019). Increased Glycolysis and Higher Lactate Production in Hyperglycemic Myotubes. Cells, 8.10.3390/cells8091101 ↗
41. Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature10.1210/js.2019-00160 ↗
42. Polyphenols and AGEs/RAGE axis. Trends and challenges10.1016/j.foodres.2019.108843 ↗
43. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells10.1016/j.jhep.2009.12.007 ↗
44. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress10.1016/j.diabet.2012.01.003 ↗
45. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands10.2337/db09-0801 ↗
46. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases10.1155/2019/3085756 ↗
47. ROS signaling cascades: Dual regulations for osteoclast and osteoblast10.1093/abbs/gmaa098 ↗
48. Skeletal involvement in patients with diabetes mellitus10.1002/dmrr.449 ↗
49. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: A review10.1089/scd.2014.0484 ↗
50. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription10.1074/jbc.M702811200 ↗
51. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice10.1016/j.cmet.2009.12.009 ↗
52. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts10.1016/j.cmet.2010.01.001 ↗
53. FoxO1 expression in osteoblasts modulates bone formation through resistance to oxidative stress in mice10.1016/j.bbrc.2018.07.055 ↗
54. p-Nonylphenol Impairment of Osteogenic Differentiation of Mesenchymal Stem Cells was Found to be Due to Oxidative Stress and Down-Regulation of RUNX2 and BMP10.2174/1871530320666200505114058 ↗
55. Li, J., He, W., Liao, B., and Yang, J. (2015). FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus. Sci. Rep., 5.10.1038/srep12724 ↗
56. Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells10.1016/j.tox.2005.07.003 ↗
57. Aluminum Induces Osteoblast Apoptosis Through the Oxidative Stress-Mediated JNK Signaling Pathway10.1007/s12011-012-9523-5 ↗
58. Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: A critical role for amino acids10.1530/JOE-12-0072 ↗
59. The impairment of glucose-stimulated insulin secretion in pancreatic β-cells caused by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive antioxidant response10.1016/j.fct.2016.12.016 ↗
60. Metabolic evolution suggests an explanation for the weakness of antioxidant defences in beta-cells10.1016/j.mad.2008.12.007 ↗
61. The effects of IRS-1 on osteogenic differentiation and the mechanism
62. Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures10.4239/wjd.v4.i4.101 ↗
63. Agidigbi, T.S., and Kim, C. (2019). Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. Int. J. Mol. Sci., 20.10.3390/ijms20143576 ↗
64. Reactive oxygen species mediate RANK signaling in osteoclasts10.1016/j.yexcr.2004.07.035 ↗
65. FOXO1 mediates RANKL-induced osteoclast formation and activity10.4049/jimmunol.1402211 ↗
66. Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy10.1093/jmcb/mjr021 ↗
67. Sul, O.J., Li, G., Kim, J.E., Kim, E.S., and Choi, H.S. (2021). 7-ketocholesterol enhances autophagy via the ROS-TFEB signaling pathway in osteoclasts. J. Nutr. Biochem., 96.10.1016/j.jnutbio.2021.108783 ↗
68. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation10.1182/blood-2004-09-3662 ↗
69. Coupling of bone resorption and formation by RANKL reverse signalling10.1038/s41586-018-0482-7 ↗
70. Flieger, J., Flieger, W., Baj, J., and Maciejewski, R. (2021). Antioxidants: Classification, Natural Sources, Activity/Capacity Measurements, and Usefulness for the Synthesis of Nanoparticles. Materials, 14.10.3390/ma14154135 ↗
71. Abedi, N., Sajadi-Javan, Z.S., Kouhi, M., Ansari, L., Khademi, A., and Ramakrishna, S. (2023). Antioxidant Materials in Oral and Maxillofacial Tissue Regeneration: A Narrative Review of the Literature. Antioxidants, 12.10.3390/antiox12030594 ↗
72. Role of antioxidants in common health diseases
73. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling10.1083/jcb.201708007 ↗
74. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species10.1159/000485089 ↗
75. The dual functions of thiol-based peroxidases in H2O2 scavenging and signaling10.1089/ars.2008.2049 ↗
76. Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation10.5830/CVJA-2013-067 ↗
77. Role of uric acid as an endogenous radical scavenger and antioxidant10.1378/chest.100.3_Supplement.176S ↗
78. Kim, D.H., Meza, C.A., Clarke, H., Kim, J.S., and Hickner, R.C. (2020). Vitamin D and Endothelial Function. Nutrients, 12.10.3390/nu12020575 ↗
79. Ascorbic acid as antioxidant10.1016/bs.vh.2022.10.008 ↗
80. The role of metabolism in the antioxidant function of vitamin E10.3109/10408449309117115 ↗
81. NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage10.1152/ajpcell.00208.2016 ↗
82. Aggarwal, B.B., Surh, Y.-J., and Shishodia, S. (2007). Antioxidant and anti-inflammatory properties of curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer.10.1007/978-0-387-46401-5 ↗
83. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives—A review10.1016/j.jtcme.2016.05.005 ↗
84. Qiu, L., Gao, C., Wang, H., Ren, Y., Li, J., Li, M., Du, X., Li, W., and Zhang, J. (2023). Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Front. Endocrinol., 14.10.3389/fendo.2023.1216708 ↗
85. Polyunsaturated fatty acids as antioxidants10.1016/j.phrs.2008.05.002 ↗
86. Stoia, M., and Oancea, S. (2022). Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends. Antioxidants, 11.10.3390/antiox11040638 ↗
87. Porosity of 3D biomaterial scaffolds and osteogenesis10.1016/j.biomaterials.2005.02.002 ↗
88. Biomaterial scaffolds in maxillofacial bone tissue engineering: A review of recent advances
89. Interactions between cells and biomaterials in tissue engineering: A review
90. Control-released Alpha-lipoic acid-loaded PLGA microspheres enhance bone formation in type 2 diabetic rat model
91. Different approaches to synthesising cerium oxide nanoparticles and their corresponding physical characteristics, and ROS scavenging and anti-inflammatory capabilities10.1039/D1TB01091C ↗
92. Polydopamine-mediated graphene oxide and nanohydroxyapatite-incorporated conductive scaffold with an immunomodulatory ability accelerates periodontal bone regeneration in diabetes
93. Docosahexaenoic acid improves altered mineralization proteins, the decreased quality of hydroxyapatite crystals and suppresses oxidative stress induced by high glucose10.3892/etm.2022.11160 ↗
94. Lin, C.W., Lee, C.Y., Lin, S.Y., Kang, L., Fu, Y.C., Chen, C.H., and Wang, C.K. (2022). Bone-Targeting Nanoparticles of a Dendritic (Aspartic acid)(3)-Functionalized PEG-PLGA Biopolymer Encapsulating Simvastatin for the Treatment of Osteoporosis in Rat Models. Int. J. Mol. Sci., 23.10.3390/ijms231810530 ↗
95. Non-Covalent Self-Assembly and Covalent Polymerization Co-Contribute to Polydopamine Formation10.1002/adfm.201201156 ↗
96. Li, H., Xi, J., Donaghue, A.G., Keum, J., Zhao, Y., An, K., McKenzie, E.R., and Ren, F. (2020). Synthesis and catalytic performance of polydopamine supported metal nanoparticles. Sci. Rep., 10.10.1038/s41598-020-67458-9 ↗
97. Polydopamine free radical scavengers10.1039/D0BM01070G ↗
98. Gaucher, C., Boudier, A., Bonetti, J., Clarot, I., Leroy, P., and Parent, M. (2018). Glutathione: Antioxidant Properties Dedicated to Nanotechnologies. Antioxidants, 7.10.3390/antiox7050062 ↗
99. 3D printing of reduced glutathione grafted gelatine methacrylate hydrogel scaffold promotes diabetic bone regeneration by activating PI3K/Akt signaling pathway10.1016/j.ijbiomac.2022.09.236 ↗
100. Singh, R.K., Yoon, D.S., Mandakhbayar, N., Li, C., Kurian, A.G., Lee, N.-H., Lee, J.-H., and Kim, H.-W. (2022). Diabetic bone regeneration with nanoceria-tailored scaffolds by recapitulating cellular microenvironment: Activating integrin/TGF-β co-signaling of MSCs while relieving oxidative stress. Biomaterials, 288.10.1016/j.biomaterials.2022.121732 ↗